332 related articles for article (PubMed ID: 25745310)
1. Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study.
Sadeghian H; Motiei-Langroudi R
Ann Indian Acad Neurol; 2015; 18(1):45-8. PubMed ID: 25745310
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
3. Comparing Prophylactic Effect of Levetiracetam, Sodium Valproate, and Propranolol in Pediatric Migraine: A Randomized Clinical Trial.
Fayyazi A; Pezeshki N; Mansuri H; Khajeh A
Iran J Child Neurol; 2023; 17(4):105-115. PubMed ID: 38074934
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India.
Verma A; Srivastava D; Kumar A; Singh V
Clin Neuropharmacol; 2013; 36(6):193-7. PubMed ID: 24201237
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis.
Tsaousi G; Pourzitaki C; Siafis S; Kyrgidis A; Grosomanidis V; Kouvelas D; Papazisis G
Eur J Clin Pharmacol; 2020 Feb; 76(2):161-174. PubMed ID: 31768574
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam for the Prophylaxis of Migraine in Adults.
Azeem GM; Faheem F; Farooq N; Sohail D; Rehman A; Javed MU
Cureus; 2021 Jul; 13(7):e16779. PubMed ID: 34513386
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of levetiracetam for migraine prophylaxis: A systematic review and meta-analysis.
Yen PH; Kuan YC; Tam KW; Chung CC; Hong CT; Huang YH
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):755-764. PubMed ID: 32861551
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
Watkins AK; Gee ME; Brown JN
J Clin Pharm Ther; 2018 Aug; 43(4):467-475. PubMed ID: 29781197
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial.
Montazerlotfelahi H; Amanat M; Tavasoli AR; Agah E; Zamani GR; Sander JW; Badv RS; Mohammadi M; Dehghani M; Heidari M; Hosseini SA; Salehi M; Ashrafi MR
Cephalalgia; 2019 Oct; 39(12):1509-1517. PubMed ID: 31154809
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant drugs for migraine prophylaxis.
Chronicle E; Mulleners W
Cochrane Database Syst Rev; 2004; (3):CD003226. PubMed ID: 15266476
[TBL] [Abstract][Full Text] [Related]
13. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
[TBL] [Abstract][Full Text] [Related]
16. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
17. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study.
Hesami O; Shams MR; Ayazkhoo L; Assarzadegan F; Safarpour Lima B; Delavar Kasmaei H; Sistanizad M
Iran J Pharm Res; 2018; 17(2):783-789. PubMed ID: 29881434
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
Jackson JL; Cogbill E; Santana-Davila R; Eldredge C; Collier W; Gradall A; Sehgal N; Kuester J
PLoS One; 2015; 10(7):e0130733. PubMed ID: 26172390
[TBL] [Abstract][Full Text] [Related]
20. Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial.
Karimi N; Tavakoli M; Charati JY; Shamsizade M
Clin Exp Emerg Med; 2017 Sep; 4(3):138-145. PubMed ID: 29026887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
